Daniel S. Graciaa

629 total citations
15 papers, 181 citations indexed

About

Daniel S. Graciaa is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Daniel S. Graciaa has authored 15 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Daniel S. Graciaa's work include Tuberculosis Research and Epidemiology (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Fecal contamination and water quality (2 papers). Daniel S. Graciaa is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Fecal contamination and water quality (2 papers). Daniel S. Graciaa collaborates with scholars based in United States, Georgia and Netherlands. Daniel S. Graciaa's co-authors include Jonathan S. Yoder, Timothy J. Wade, Virginia A. Roberts, Kathleen E. Fullerton, Michael J. Beach, Elizabeth D. Hilborn, Lorraine C. Backer, Vincent R. Hill, Jennifer R. Cope and Marissa Vigar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and The Journal of Infectious Diseases.

In The Last Decade

Daniel S. Graciaa

12 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel S. Graciaa United States 6 61 54 31 28 27 15 181
Saurabh Sharma India 10 19 0.3× 46 0.9× 17 0.5× 17 0.6× 44 1.6× 46 300
Jorge Fleisher United States 7 30 0.5× 42 0.8× 8 0.3× 43 1.5× 22 0.8× 15 210
Όλγα Παππά Greece 10 20 0.3× 43 0.8× 11 0.4× 17 0.6× 10 0.4× 15 240
Abeer Alassaf Jordan 11 56 0.9× 16 0.3× 22 0.7× 54 1.9× 10 0.4× 32 318
Raisa Hannula Norway 7 89 1.5× 27 0.5× 6 0.2× 75 2.7× 18 0.7× 10 151
Ellen Besa United Kingdom 11 57 0.9× 11 0.2× 29 0.9× 17 0.6× 215 8.0× 23 332
Adey Feleke Desta Ethiopia 9 38 0.6× 30 0.6× 4 0.1× 21 0.8× 17 0.6× 24 212
Mehul Kumar Chourasia United Kingdom 11 40 0.7× 40 0.7× 13 0.4× 8 0.3× 7 0.3× 18 251
Kanekwa Zyambo Zambia 12 60 1.0× 11 0.2× 29 0.9× 30 1.1× 220 8.1× 29 418
Shanon Smith United States 6 65 1.1× 24 0.4× 8 0.3× 4 0.1× 59 2.2× 9 189

Countries citing papers authored by Daniel S. Graciaa

Since Specialization
Citations

This map shows the geographic impact of Daniel S. Graciaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Graciaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Graciaa more than expected).

Fields of papers citing papers by Daniel S. Graciaa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Graciaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Graciaa. The network helps show where Daniel S. Graciaa may publish in the future.

Co-authorship network of co-authors of Daniel S. Graciaa

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Graciaa. A scholar is included among the top collaborators of Daniel S. Graciaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Graciaa. Daniel S. Graciaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Graciaa, Daniel S., Stephen R. Walsh, & Nadine Rouphael. (2024). Human Immunodeficiency Virus Vaccine. Infectious Disease Clinics of North America. 38(3). 475–485. 2 indexed citations
2.
Graciaa, Daniel S., et al.. (2024). Systems Vaccinology: Navigating the Future of Personalized Immunity and Next-Generation Vaccines. The Journal of Infectious Diseases. 230(6). 1305–1308. 1 indexed citations
3.
Graciaa, Daniel S., et al.. (2023). Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies. Expert Review of Anti-infective Therapy. 21(6). 595–616. 3 indexed citations
4.
Graciaa, Daniel S., Hans Verkerke, Jeannette Guarner, et al.. (2022). Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021. SHILAP Revista de lepidopterología. 2(1). e159–e159. 2 indexed citations
5.
Graciaa, Daniel S., Russell R. Kempker, Yun F. Wang, et al.. (2022). SARS-CoV-2 seroprevalence among healthcare personnel at a large health system in Atlanta. The American Journal of the Medical Sciences. 364(3). 296–303.
6.
Rouphael, Nadine, et al.. (2022). Is the BCG Vaccine an Answer to Future Pandemic Preparedness?. Vaccines. 10(2). 201–201.
7.
Graciaa, Daniel S., et al.. (2022). Sweet Syndrome Imitating Cutaneous Cryptococcal Disease. Open Forum Infectious Diseases. 9(11). ofac608–ofac608. 7 indexed citations
8.
Graciaa, Daniel S., Maia Kipiani, Matthew J. Magee, et al.. (2022). Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. 66(9). e0040822–e0040822. 7 indexed citations
9.
Kipiani, Maia, et al.. (2021). Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis. Open Forum Infectious Diseases. 8(12). ofab551–ofab551. 2 indexed citations
10.
Graciaa, Daniel S., Jennifer R. Cope, Virginia A. Roberts, et al.. (2018). Outbreaks Associated with Untreated Recreational Water — United States, 2000–2014. American Journal of Transplantation. 18(8). 2083–2087. 40 indexed citations
11.
Graciaa, Daniel S., Matthew H. Collins, & Henry M. Wu. (2018). Zika in 2018: Advising Travelers Amid Changing Incidence. Annals of Internal Medicine. 169(5). 337–338. 4 indexed citations
12.
Graciaa, Daniel S., et al.. (2018). A survey of the tuberculosis physician workforce in the country of Georgia. The International Journal of Tuberculosis and Lung Disease. 22(11). 1286–1292. 3 indexed citations
13.
Graciaa, Daniel S., Jennifer R. Cope, Virginia A. Roberts, et al.. (2018). Outbreaks Associated with Untreated Recreational Water — United States, 2000–2014. MMWR Morbidity and Mortality Weekly Report. 67(25). 701–706. 88 indexed citations
14.
Graciaa, Daniel S., Marina Mošunjac, Kimberly Workowski, & Russell R. Kempker. (2017). Asymptomatic Cardiovascular Syphilis With Aortic Regurgitation Requiring Surgical Repair in an HIV-Infected Patient. Open Forum Infectious Diseases. 4(4). ofx198–ofx198. 7 indexed citations
15.
Musselman, Dominique L., Erica Royster, Ming Wang, et al.. (2013). The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings. Neuropsychopharmacology. 38(10). 1921–1928. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026